BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28945293)

  • 1. Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study.
    da Fonseca FL; Yamanaka PK; Mazoti L; Arakawa-Sugueno L; Kato JM; Matayoshi S
    Head Neck; 2017 Dec; 39(12):2381-2396. PubMed ID: 28945293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.
    Solans R; Bosch JA; Galofré P; Porta F; Roselló J; Selva-O'Callagan A; Vilardell M
    J Nucl Med; 2001 May; 42(5):738-43. PubMed ID: 11337569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
    Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
    J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
    Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.
    Wu JQ; Feng HJ; Ouyang W; Sun YG; Chen P; Wang J; Xian JL; Huang LH
    Nucl Med Commun; 2015 Aug; 36(8):819-26. PubMed ID: 25932534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
    Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
    Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
    Caglar M; Tuncel M; Alpar R
    Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.
    Almeida JP; Sanabria AE; Lima EN; Kowalski LP
    Head Neck; 2011 May; 33(5):686-90. PubMed ID: 21484917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study.
    Zettinig G; Hanselmayer G; Fueger BJ; Hofmann A; Pirich C; Nepp J; Dudczak R
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1428-32. PubMed ID: 12397459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.
    Bohuslavizki KH; Brenner W; Klutmann S; Hübner RH; Lassmann S; Feyerabend B; Lüttges J; Tinnemeyer S; Clausen M; Henze E
    J Nucl Med; 1998 Jul; 39(7):1237-42. PubMed ID: 9669401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin.
    Rosario PW; Calsolari MR
    Thyroid; 2013 May; 23(5):617-9. PubMed ID: 23136908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma.
    Fard-Esfahani A; Mirshekarpour H; Fallahi B; Eftekhari M; Saghari M; Beiki D; Ansari-Gilani K; Takavar A
    Clin Nucl Med; 2007 Sep; 32(9):696-9. PubMed ID: 17710021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sialendoscopy on improving health related quality of life in patients suffering from radioiodineinduced xerostomia.
    Bulut OC; Haufe S; Hohenberger R; Hein M; Kratochwil C; Rathke H; Plinkert PK; Baumann I; Holland-Letz T; Haberkorn U; Flechsig P
    Nuklearmedizin; 2018 Aug; 57(4):160-167. PubMed ID: 30125928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors of
    Hollingsworth B; Senter L; Zhang X; Brock GN; Jarjour W; Nagy R; Brock P; Coombes KR; Kloos RT; Ringel MD; Sipos J; Lattimer I; Carrau R; Jhiang SM
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4085-4093. PubMed ID: 27533304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacrimal System Obstruction After Radioiodine Therapy in Differentiated Thyroid Carcinomas: A Prospective Comparative Study.
    da Fonseca FL; Yamanaka PK; Kato JM; Matayoshi S
    Thyroid; 2016 Dec; 26(12):1761-1767. PubMed ID: 27565021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Xerostomia and Ultrasonographic Features of the Major Salivary Glands After Radioactive Iodine Ablation for Papillary Thyroid Carcinoma.
    Soo Roh S; Wook Kim D; Jin Baek H
    AJR Am J Roentgenol; 2016 Nov; 207(5):1077-1081. PubMed ID: 27504709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland toxicity after radioiodine therapy for thyroid cancer.
    Hyer S; Kong A; Pratt B; Harmer C
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):83-6. PubMed ID: 17305259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.
    Bohuslavizki KH; Klutmann S; Bleckmann C; Brenner W; Lassmann S; Mester J; Henze E; Clausen M
    Strahlenther Onkol; 1999 Feb; 175(2):57-61. PubMed ID: 10065139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia.
    Bhayani MK; Acharya V; Kongkiatkamon S; Farah S; Roberts DB; Sterba J; Chambers MS; Lai SY
    Thyroid; 2015 Jul; 25(7):834-8. PubMed ID: 25860842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.